- Report
- February 2023
- 175 Pages
Global
From €4484EUR$5,000USD£3,845GBP
- Report
- January 2025
- 375 Pages
Global
From €4484EUR$5,000USD£3,845GBP
- Report
- March 2022
- 300 Pages
Global
From €4484EUR$5,000USD£3,845GBP
- Report
- September 2025
- 70 Pages
India
From €3139EUR$3,500USD£2,691GBP
- Report
- September 2025
- 70 Pages
India
From €3139EUR$3,500USD£2,691GBP
- Report
- September 2025
- 70 Pages
India
From €3139EUR$3,500USD£2,691GBP
- Report
- August 2024
- 80 Pages
Japan
From €3139EUR$3,500USD£2,691GBP
- Report
- August 2024
- 80 Pages
Japan
From €3139EUR$3,500USD£2,691GBP
- Report
- May 2024
- 185 Pages
Global
From €4035EUR$4,500USD£3,460GBP
- Report
- October 2023
- 89 Pages
Japan
From €3139EUR$3,500USD£2,691GBP
- Report
- October 2023
- 190 Pages
Global
From €4035EUR$4,500USD£3,460GBP
- Report
- August 2025
- 86 Pages
India
From €3139EUR$3,500USD£2,691GBP
- Report
- February 2024
- 185 Pages
Global
From €4035EUR$4,500USD£3,460GBP
- Report
- September 2023
- 88 Pages
Israel
From €3139EUR$3,500USD£2,691GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1794EUR$2,000USD£1,538GBP
- Report
- July 2025
- 150 Pages
Global
From €3363EUR$3,750USD£2,884GBP
- Clinical Trials
- July 2025
- 80 Pages
Global
From €1794EUR$2,000USD£1,538GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1794EUR$2,000USD£1,538GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1794EUR$2,000USD£1,538GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1794EUR$2,000USD£1,538GBP

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more